By John Stanford The Federal Trade Commission just announced plans to “take an aggressive approach to tackling anticompetitive pharmaceutical mergers.” Kelly Slaughter, the acting head of the agency, recently blamed the “high volume of pharmaceutical mergers in recent years … [for] skyrocketing drug prices.” Not only are her actions without merit, but they also imperil […]
EXCEPT WHERE INDICATED, THE OPINIONS EXPRESSED ON THIS PAGE ARE NOT NECESSARILY THOSE OF THE MADISON TIMES
Private Sector Investment Fuels Drug Development
By Nina Nguyen The FDA just approved a groundbreaking new treatment for cystic fibrosis, a disease that causes a life-threatening buildup of mucus in the lungs. This drug offers hope to the 30,000 Americans who suffer from this disease, many of whom lack viable treatment options. With the approval of this drug, cystic fibrosis patients […]